Skip to main content

Wacker v. JPMorganChase

Image result for silver coins worth

Was JPMorganChase manipulating the price of silver and/.or silver futures in the markets in 2010-11?

I submit that the question is one of historical importance, not of importance merely to the parties directly involved in the litigation captioned above.

Further, I expect that a trial on this question will aid the historians of posterity, bringing to light valuable data on this point, and thus on the significance of precious metals as a Magoffin in the post-Crisis financial world.

If you're a law student, and are taking the Civil Pro course, dear reader, this case might also be a valuable introduction for you into the vagaries of pleadings law.

http://www.reuters.com/article/us-jpmorgan-lawsuit-silver-idUSKBN15G4Z 

But let's get back to the point: WHY is this case of historical importance? It may clarify judges and parties' attitudes toward the traditional Precious metals, gold predominantly but silver as well, once thought of as the paradigmatic form of Money.

The prices of silver and gold can be volatile precisely because there is a background feeling that they are something other than just another commodity,suitable for jewelry. These are traditional bearers of and metrics for VALUE.

Bryan recommended -- indeed DEMANDED -- the coinage of silver as an alternative to the sacrifice of mankind on a cross of gold. The only alternative to the one metal was bi-metallism. The notion of understanding money as paper issued by a govt or central bank would have struck even the most eager monetary reformers of Bryan's day as wild-eyed.

Sentiment about metals as real money in turn makes the manipulation of silver prices a fraught matter.

Comments

  1. eToro is the best forex trading platform for beginning and established traders.

    ReplyDelete

Post a Comment

Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.



We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…